Hims Hers Health Inc is trading 4.7% down today at $33.81.
- Chief Medical Officer Patrick Carroll filed to sell up to 23,726 shares worth about $830,000 on Thursday, potentially contributing to today's pullback.
- The decline follows a sharp multi-day run-up and comes amid ongoing volatility tied to its GLP-1 weight-loss offering, as well as a regulatory overhang from previous FDA actions and a Novo Nordisk lawsuit.
- Shares continue to exhibit high sensitivity to news surrounding the GLP-1 market and the company's specific compounding status, with a key FDA peptide review meeting scheduled for July.